Live
Endpoints News#AAD26: Biogen declares Phase 2 lupus success for anti-BDCA2 antibodyFierceBiotechTakeda clears path to FDA with phase 3 data on $4B psoriasis betCellAdvancing precision health discovery in a genetically diverse health systemCellWhole-body molecular and cellular mapping of the laboratory mouseEndpoints News#AAD26: Tanabe’s Phase 3 win for drug targeting rare diseases that cause pain upon light exposureThermo FisherGenerate Investment Management Ltd Has $20.66 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeatEndpoints NewsA week of bolt-on deals; Wave crashes on obesity data; Sanofi partners with TCE startup; and moreIlluminaExchange Traded Concepts Trims Illumina Stock Holdings - National Today10x Genomics BlogJPMorgan Chase & Co. Raises Position in 10x Genomics $TXG - MarketBeatThermo FisherThermo Fisher Scientific Shares Sold by DAVENPORT & Co LLC - National TodayIlluminaExchange Traded Concepts LLC Lowers Stock Holdings in Illumina, Inc. $ILMN - MarketBeatLonza NewsLonza Group AG Stock: A Key Player in Biopharma Manufacturing for North American Investors - AD HOC NEWS
Endpoints News Mar 28, 2026

#AAD26: Biogen declares Phase 2 lupus success for anti-BDCA2 antibody

#AAD26: Biogen declares Phase 2 lupus success for anti-BDCA2 antibody

Original
Body unavailable. Use the original source.

Directory

59 All